1400 Participants Needed

Pericardiotomy for Cardiovascular Disease

(PRINCE Trial)

Recruiting at 2 trial locations
RW
PC
Overseen ByPRINCE Coordinators
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Population Health Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Left Posterior Pericardiotomy for cardiovascular disease?

Research shows that the treatment, Left Posterior Pericardiotomy, is effective in reducing the risk of atrial fibrillation (a type of irregular heartbeat) after heart surgery by allowing better drainage of fluids that can irritate the heart.12345

Is posterior pericardiotomy generally safe for humans?

Posterior pericardiotomy has been studied in the context of heart surgery and is associated with a reduction in atrial fibrillation (irregular heartbeat) and pericardial effusion (fluid around the heart) after surgery, suggesting it is generally safe when performed in this setting.13456

How is the treatment Left Posterior Pericardiotomy different from other treatments for cardiovascular disease?

Left Posterior Pericardiotomy is unique because it involves a surgical incision to allow drainage of blood and fluid, reducing irritation to the heart and preventing atrial fibrillation after cardiac surgery, unlike other treatments that may not address this specific cause.13457

What is the purpose of this trial?

PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery.

Research Team

RW

Richard Whitlock

Principal Investigator

Population Health Research Institute

EB

Emilie Belley-Côté

Principal Investigator

Population Health Research Institute

MG

Mario Gaudino

Principal Investigator

Weill Medical College of Cornell University

SS

Sigrid Sandner, MD

Principal Investigator

Medical University Vienna

BR

Björn Redfors

Principal Investigator

Göteborg University

Eligibility Criteria

This trial is for adults over 18 who need heart surgery on the aorta, valves, or coronary arteries and can give informed consent. It's not for those with a history of atrial fibrillation or flutter.

Inclusion Criteria

I am capable of understanding and agreeing to the trial's terms.
I need surgery on my heart or the main blood vessel coming from it.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo cardiac surgery with or without left posterior pericardiotomy

Immediate post-surgery period
In-hospital stay

Follow-up

Participants are monitored for safety and effectiveness after treatment

5 years
Follow-up visits at 1 month, 6 months, and every 6 months thereafter

Post-operative Monitoring

Monitoring for post-operative atrial fibrillation and other safety outcomes

30 days

Treatment Details

Interventions

  • Left Posterior Pericardiotomy
Trial Overview The PRINCE trial is testing if doing a left posterior pericardiotomy during cardiac surgery can prevent complications like atrial fibrillation. Patients are randomly chosen to either get this procedure or not.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Left Posterior Pericardiotomy GroupExperimental Treatment1 Intervention
The surgeon will perform a left posterior pericardiotomy during the patient's cardiac surgery.
Group II: No Posterior Pericardiotomy GroupActive Control1 Intervention
The surgeon will not perform a posterior pericardiotomy during the patient's cardiac surgery.

Left Posterior Pericardiotomy is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Posterior Left Pericardiotomy for:
  • Prevention of postoperative atrial fibrillation after cardiac surgery
🇪🇺
Approved in European Union as Posterior Left Pericardiotomy for:
  • Prevention of postoperative atrial fibrillation after cardiac surgery

Find a Clinic Near You

Who Is Running the Clinical Trial?

Population Health Research Institute

Lead Sponsor

Trials
165
Recruited
717,000+

McMaster University

Collaborator

Trials
936
Recruited
2,630,000+

Hamilton Health Sciences Corporation

Collaborator

Trials
380
Recruited
345,000+

Weill Medical College of Cornell University

Collaborator

Trials
1,103
Recruited
1,157,000+

Findings from Research

Posterior pericardiotomy significantly reduces the incidence of postoperative atrial fibrillation (10.8% in the PP group vs. 28.1% in the control group) and supraventricular arrhythmias after coronary artery bypass surgery, based on a meta-analysis of 763 patients from 6 randomized studies.
The procedure also leads to a marked reduction in postoperative pericardial effusion, which is suggested to be a key factor in the development of atrial fibrillation after cardiac surgery.
Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy in preventing atrial fibrillation after coronary artery bypass surgery.Biancari, F., Mahar, MA.[2022]
In a study of 100 patients undergoing coronary artery bypass grafting, those who received posterior pericardiotomy had a significantly lower incidence of early pericardial effusion (12%) compared to those who did not undergo the procedure (42%).
The procedure also reduced the occurrence of postoperative atrial fibrillation, with only 10% of patients in the pericardiotomy group developing AF compared to 30% in the control group, indicating its efficacy in improving patient outcomes.
Effects of posterior pericardiotomy on the incidence of pericardial effusion and atrial fibrillation after coronary revascularization.Ekim, H., Kutay, V., Hazar, A., et al.[2006]
The posterior left pericardiotomy is a surgical technique designed to prevent postoperative atrial fibrillation in patients undergoing cardiac surgery by allowing for effective drainage of blood and fluid.
This procedure involves a specific incision near the phrenic nerve and is believed to reduce irritation to the left atrium, which is a contributing factor to the development of atrial fibrillation after surgery.
Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery.Lau, C., Soletti, GJ., Olaria, RP., et al.[2021]

References

Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy in preventing atrial fibrillation after coronary artery bypass surgery. [2022]
Effects of posterior pericardiotomy on the incidence of pericardial effusion and atrial fibrillation after coronary revascularization. [2006]
Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery. [2021]
Postoperative pericardial effusion, pericardiotomy, and atrial fibrillation: An explanatory analysis of the PALACS trial. [2023]
Effect of posterior pericardiotomy on postoperative supraventricular arrhythmias and late pericardial effusion (posterior pericardiotomy). [2019]
Posterior pericardiotomy reduces the incidence of supra-ventricular arrhythmias and pericardial effusion after coronary artery bypass grafting. [2019]
Posterior pericardial window: a simple and reproducible technique in order to prevent pericardial tamponade in paediatric cardiac surgery. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security